CYTO365 Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $1.09M

  • Investors
  • 4

CYTO365 General Information

Description

Manufacturer of intravenous inlets intended to provide an extra layer of security for the administration of drugs. The company offers patented luer inlets with automatic flushing with a flushing fluid that is always available, to separate drugs from mixing and rinsing the tube further down the line, providing clients with inlets to separate drugs from mixing during infusion therapy.

Contact Information

Website
www.cyto365.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Kastellgatan 4
  • 254 66 Helsingborg
  • Sweden
+46 070-964
Primary Industry
Medical Supplies
Corporate Office
  • Kastellgatan 4
  • 254 66 Helsingborg
  • Sweden
+46 070-964

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CYTO365 Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 12-Dec-2023 $1.09M Completed Generating Revenue
3. Later Stage VC 01-Nov-2022 Completed Generating Revenue
2. Grant 05-Oct-2022 $1.92M $530K Completed Generating Revenue
1. Later Stage VC 31-Dec-2019 $530K $530K Completed Generating Revenue
To view CYTO365’s complete valuation and funding history, request access »

CYTO365 Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preference
To view CYTO365’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

CYTO365 Patents

CYTO365 Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4015030-A1 An improved tactical feel for a multilevel stopcock Active 18-Dec-2020
EP-4015030-B1 An improved tactical feel for a multilevel stopcock Active 18-Dec-2020
EP-4015030-C0 An improved tactical feel for a multilevel stopcock Active 18-Dec-2020
ES-3035994-T3 An improved tactical feel for a multilevel stopcock Active 18-Dec-2020
AU-2021295867-A1 A closed-system type female connector, a method for manufacture, and a stopcock having such female connectors Pending 24-Jun-2020 A61M39/22
To view CYTO365’s complete patent history, request access »

CYTO365 Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CYTO365 Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Life Science Invest Angel Group Minority
Svanberg & Co Invest PE/Buyout Minority
European Innovation Council Accelerator/Incubator Minority
Horizon Europe Not-For-Profit Venture Capital
To view CYTO365’s complete investors history, request access »

CYTO365 FAQs

  • When was CYTO365 founded?

    CYTO365 was founded in 2013.

  • Where is CYTO365 headquartered?

    CYTO365 is headquartered in Helsingborg, Sweden.

  • What is the size of CYTO365?

    CYTO365 has 10 total employees.

  • What industry is CYTO365 in?

    CYTO365’s primary industry is Medical Supplies.

  • Is CYTO365 a private or public company?

    CYTO365 is a Private company.

  • What is CYTO365’s current revenue?

    The current revenue for CYTO365 is .

  • How much funding has CYTO365 raised over time?

    CYTO365 has raised $3.08M.

  • Who are CYTO365’s investors?

    Life Science Invest, Svanberg & Co Invest, European Innovation Council, and Horizon Europe have invested in CYTO365.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process